Andrew Lee's Contact Details

Andrew Lee's Company Details

C&L Therapeutics, Inc.

, Daejeon, South Korea • 1 Employees
Research

C&L Therapeutics is a private, discovery-stage biopharmaceutical company focused on developing 1st in-class drugs for the treatment of age-related sarcopenia and other neuromuscular degenerative diseases. Our pipeline includes a small molecule drug targeting sarcopenia, which effectively reverses the loss of skeletal muscle protein and recovers the muscle strength in animal studies. We also develop a direct cell reprogramming agent to generate clinically relevant cell types from patient-derived differentiated somatic cells via "trans-differentiation". This approach can provide a powerful tool for regenerative, precision medicine.